HomeResearch & Knowledgeback to HomeEntrepreneurshipback to Research & KnowledgeLeading a Surgical Revolutionback to Entrepreneurship

Book

Leading a Surgical Revolution

The AO Foundation - Social entrepreneurs in the treatment of bone trauma

By Jean-Pierre Jeannet

401 pages

Hardcover

Overview

Keep reading

Overview

Keep reading

This book describes the 60-year history of the AO Foundation and its impact on the treatment of bone trauma.

Originally founded by a group of Swiss surgeons, the AO has since established its osteosynthesis treatment approach to trauma, using surgery and implants, as the global standard. The AO successfully convinced the medical community that surgery of bone trauma was superior to the standard conservative treatment using plaster casts. This new technique meant that patients no longer had to spend long weeks at the hospital in traction, and prevented many disabilities.

This book describes the struggle with the medical community, explains how the AO surgeons enlisted the support of an entire industry for their advanced tools and their research and teaching efforts, and details the AO’s evolution into a non-profit foundation that now trains more than 50,000 surgeons, on all continents, every year.

The efforts of the AO’s affiliated surgeons, undertaken largely on a volunteer basis and with their own financial resources, serve as a stellar example of social entrepreneurship. Today the AO Foundation numbers over 20,000 surgeon members worldwide, and the industry that emerged to produce related implants and tools employs thousands of skilled staff. Professionals in consulting as well as in healthcare can use this book as a source of successful strategies, and as a blueprint for active social entrepreneurship.

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Hardcover

eBook

You can also buy the book on Barnes & Nobles, Book Depository, Orell Füssli and Routledge.

Publisher

Springer

ISBN

9783030019792

Keep reading

Case Study

Oculis: Transforming ophthalmology a drop at a time

Start-up Venture Capital Entrepreneurship Strategy

By Benoit F. Leleux, Abdulaziz A. AlSayyari, Barbara Müller and Vladimir Novotny

Video

Clee Medical: Making brain surgery safer

Swiss startup Clee Medical is revolutionizing brain surgery with real-time imaging technology that boosts precision, safety, and patient outcomes.

Entrepreneurship Innovation Technology Management

By Jim Pulcrano

in I by IMD

Article

Ethnography in Entrepreneurship research: Promises, pitfalls, and practical pathways

We seek to make ethnography more intelligible and accessible to entrepreneurship scholars. We begin by defining ethnography and discussing the promises and challenges of conducting ethnographic studies in entrepreneurship. Next, we offer practical...

Entrepreneurship

By Eliana Crosina, Marco Mismetti, Alfredo De Massis, Michael G. Pratt and Trenton A. Williams

in Entrepreneurship Theory and Practice

November 2025, vol. 49, no. 6, pp. 1499–1534, https://doi.org/10.1177/10422587251364820

Article

Risky business: Comparing the opportunity evaluation decisions of social and commercial entrepreneurs

Via a choice-based conjoint experiment and Hierarchical Bayesian Analysis (HBA) of 2538 decisions from 141 entrepreneurs, we model opportunity evaluations as a utility maximizing response to identify and compare part-worth utilities for distinct l...

Social Innovation Entrepreneurship

By Matthew Bird, Patrick Reichert and Vanina Farber

in Economic Letters

October 2025, vol. 256, 112634, https://doi.org/10.1016/j.econlet.2025.112634

Article

Entrepreneurship as an academic field: Taking stock and new directions

Entrepreneurship has emerged as a vibrant and dynamic field of academic inquiry, capturing the attention of scholars in management and other social science and engineering disciplines. Its significance extends beyond academia to policymakers and p...

Entrepreneurship

By Sophie Bacq, Maribel Guerrero, Donald Siegel and Jonathan Pinto

in International Journal of Management Reviews

October 2025, vol. 27, no. 4, pp. 457-465, https://doi.org/10.1111/ijmr.70001

Article

Legacy-driven innovation: Lessons from Europe’s family business ecosystems

Across various European regions, particularly in areas rich in small and medium-sized enterprises (SMEs), we find vibrant networks of family firms that contribute to both economic vitality and social resilience. These entrepreneurial ecosystem...

Family Business Entrepreneurship Innovation

By Alfredo De Massis and Vittoria Magrelli

in Capital Insights

July-September 2025, vol. 2 issue 3, pp. 73-75

Case Study

Evoco AG: Unlocking private equity potential

Entrepreneurship Finance Venture Capital

By Benoit F. Leleux and Ricardo Rodriguez Plazas

Article

Psychological perspectives of owner-managers on voluntary retirement

The study aims to assist small- and medium-sized enterprises (SMEs) in preparing for the retirement of their owner-managers and smoothing their management transition. It explores how owner-managers perceive and navigate their retirement journey fr...

Family Business Entrepreneurship

By Lea Wang, Jung Eung Park and Benoit F. Leleux

in International Journal of Entrepreneurial Behaviour and Research

12 September 2025, ePub before print, https://doi.org/10.1108/IJEBR-05-2024-0550

Podcast

Uncertainty and Enterprise: Amar Bhidé on risk, imagination, and innovation

In this I by IMD podcast, Stefan Michel and Amar Bhide explore risk vs uncertainty, AI’s pitfalls, and how imagination drives innovation.

Entrepreneurship Innovation

By Stefan Michel

in I by IMD

Oculis: Transforming ophthalmology a drop at a time

By Benoit F. Leleux Abdulaziz A. AlSayyari Barbara Müller and Vladimir Novotny
Case reference: IMD-2692 ©2025

Summary

For the team at Oculis, the announcement of the new USD 100 million fundraising could not have come at a more opportune moment. The biopharmaceutical startup was founded in 2017 to transform ophthalmology by developing not only original delivery mechanisms but also groundbreaking treatments for eye diseases like Diabetic Macular Edema (DME). Established by seasoned industry experts, Oculis aimed to replace invasive eye treatments with more accessible, patient-friendly solutions such as topical eye drops. The initial research conducted in a laboratory in Iceland led to a pipeline of drug candidates, now at various stages of clinical testing. The firm continued to ramp up thanks to successive rounds of financing from top investors and partners, totaling more than USD 500 million at the end of 2024. However, it also faced some dramatic events, including the sudden death in early 2024 of its CTO. The company continued to scale, strategically balancing clinical advancements with regulatory milestones. The recent secondary offering on Nasdaq would accelerate the clinical development pipeline, in particular its novel neuroprotective candidate Prisosegtor (OCS-05), OCS-01, a topical eye drop for DME, and OCS-02, a topical biologic eye drop candidate for dry eye disease. Oculis now grappled with a number of strategic decisions, with two questions in particular concerning the team. Should it rely mostly on outsourcing production to a contract development and manufacturing organization (CDMO) or develop its own in-house manufacturing capabilities? There were strong benefits and drawbacks to both approaches. It faced a related dilemma with its product pipeline. Should it continue to rely on its own R&D, as in the past, or should it consider acquiring technologies outside, through M&A activities?

Reference IMD-2692

Organization Oculis

Industry Healthcare, Pharmaceuticals

Available Languages English

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Start-up

Venture Capital

Entrepreneurship

Strategy

Browse all topics

Clee Medical: Making brain surgery safer

By Jim Pulcrano
in I by IMD

Summary

Swiss startup Clee Medical is revolutionizing brain surgery with real-time imaging technology that boosts precision, safety, and patient outcomes.

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Entrepreneurship

Innovation

Technology Management

Browse all topics

Ethnography in Entrepreneurship research: Promises, pitfalls, and practical pathways

By Eliana Crosina Marco Mismetti Alfredo De Massis Michael G. Pratt and Trenton A. Williams
in Entrepreneurship Theory and Practice November 2025, vol. 49, no. 6, pp. 1499–1534, https://doi.org/10.1177/10422587251364820

Summary

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Entrepreneurship

Browse all topics

Risky business: Comparing the opportunity evaluation decisions of social and commercial entrepreneurs

By Matthew Bird Patrick Reichert and Vanina Farber
in Economic Letters October 2025, vol. 256, 112634, https://doi.org/10.1016/j.econlet.2025.112634

Summary

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Social Innovation

Entrepreneurship

Browse all topics

Legacy-driven innovation: Lessons from Europe’s family business ecosystems

By Alfredo De Massis and Vittoria Magrelli
in Capital Insights July-September 2025, vol. 2 issue 3, pp. 73-75

Summary

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Family Business

Entrepreneurship

Innovation

Browse all topics

Evoco AG: Unlocking private equity potential

By Benoit F. Leleux and Ricardo Rodriguez Plazas
Case reference: IMD-2689 ©2025

Summary

Michel Galeazzi and Felix Ackermann, founding partners of the private equity firm Evoco, sat with the rest of the team pondering the latest strategic issues. Evoco had evolved significantly as a fund manager since its creation in 2012, taking advantage of newly identified opportunities and developing novel competencies. Its first three funds had an excellent track record, which provided a strong platform to continue learning and to evolve the business models of its funds. Evoco's founding premise was to develop business solutions for governance and liquidity issues that emerged in private equity, creating investment opportunities for its investors in the process. The first two funds, Evoco TSE I and II, focused primarily on developing secondary solutions for liquidity and governance issues in private equity, i.e. acquiring portfolios of positions in late-stage or undermanaged buyout funds, and creating value by accelerating exits and engineering a palette of value-creating, hands-on strategic initiatives. The sellers typically required liquidity for some reason, e.g. new investment paradigms, better allocation opportunities or team reorganization. With Evoco TSE III, the strategy was refined, opening the door to single-asset deals and ever more original value creation interventions facilitated by majority ownership positions. When US President Donald Trump announced a tsunami of new tariffs on 'Liberation Day' 2 April 2025, the world of trade and industry was thrown into disarray, and private equity with it. Would it make sense to capitalize on the upheaval by tweaking the firm's strategy again to fine-tune an even more compelling investment proposition? Which direction should that take?

Reference IMD-2689

Organization Evoco

Industry Finance and Insurance, Private Equity

Available Languages English

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Entrepreneurship

Finance

Venture Capital

Browse all topics

Psychological perspectives of owner-managers on voluntary retirement

By Lea Wang Jung Eung Park and Benoit F. Leleux
in International Journal of Entrepreneurial Behaviour and Research 12 September 2025, ePub before print, https://doi.org/10.1108/IJEBR-05-2024-0550

Summary

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Family Business

Entrepreneurship

Browse all topics